In a Very Well Health story about how “moon face” is related to Cushing syndrome, Maria Fleseriu, M.D., says: “Round and reddish face, also called moon face, is frequently observed in [Cushing syndrome], but differential diagnosis is broad, and there are many other causes, including rapid weight gain of different causes, autoimmune or skin conditions.”

OHSU and research collaborators receive $4 million from the U.S. Department of Defense to look into the underlying factors contributing to the increased risk of Parkinson’s disease in people who experience sleep disturbances and post-traumatic stress disorder.

Cristiane Miranda França, D.D.S, Ph.D., comments on a research team at Tufts University School of Dentistry who grew a mixture of pig and human tooth cells in pieces of pig teeth to create bioengineered structures that resemble real human teeth: “[Yelick] applied basic science to develop a tooth. And it’s amazing."

OPB’s “Think Out Loud” interviews Steve Stadum about rejoining OHSU as interim president, and the opportunities and challenges the university faces: “I’m so proud to be back and I’m so proud of the institution. Everything it does every day is so great for Oregonians and so important. I think the biggest change since I left is [that] it’s continued to grow a lot and OHSU has become even more, I think, important to Oregonians, particularly rural and underserved patients. There’s more need now, I think. In coming out of the pandemic, I’ve certainly noticed there has been pent-up need for patient care, [a] pent-up demand and frankly more complex cases.”

Dr. Esther Choo, professor of Emergency Medicine at Oregon Health & Science University, was on the review panel for one of the cancelled sessions. Choo’s session last Thursday was set to review projects addressing the opioid crisis. She told the Capital Chronicle the cancellations were unprecedented in her career. “I have never seen it stop for any amount of time,” said Choo. “I haven’t yet encountered a researcher who remembers study sections and reviews being paused.”

Medical Dialogues reports on an OHSU study looking at the relationship between BMI and mediation-induced abortion.

The National Cancer Institute awarded OHSU $1.4 million in funding to develop a new training program to give M.D. and Ph.D. postdoctoral fellows hands-on experience with the process of developing novel therapeutics for patients with cancer. Shivaani Kummar, M.D., says, “We are committed to developing new treatments for cancer, and that commitment involves training the next generation of oncology physicians and researchers.”

The Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades; Kimberly Mauer, M.D., says, "The more options we have, the better we’re able to treat each and every patient.”

OHSU is a collaborative partner in a new research project showing early promise in the treatment of Parkinson's disease in fruit flies.

Media outlets report on a new non-opioid pain reliever approved by the FDA — the first to be approved in more than two decades. Kimberly Mauer M.D., says, “The more options we have, the better we’re able to treat each and every patient … .[Insurance coverage] might limit some patients getting it, so we just have to kind of see, and it’s hard to tell until it kind of gets out on the market.”